DOD Publishes Biomanufacturing Strategy and RFI on Biomanufactured Products and Process Capabilities DEADLINE April 19, 2023
by Lynn L. Bergeson and Carla N. Hutton (Bergeson & Campbell) As part of the National Biotechnology and Biomanufacturing Initiative, the U.S. Department of Defense (DOD) announced in September 2022 an investment of $1.2 billion in bioindustrial domestic manufacturing infrastructure